X4 Pharmaceuticals Inc.
0.46
0.00 (0.92%)
At close: Jan 15, 2025, 1:46 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
PE Ratio -1.47 -0.67 -0.66 -2.08 -2.18 -0.15 -0.78 -3.4 -5.91
PS Ratio n/a n/a n/a 43.03 n/a 1.83 n/a n/a n/a
PB Ratio 2.92 0.85 0.92 1.77 0.95 0.30 0.45 -1.38 -2.28
P/FCF Ratio -1.54 -0.82 -0.82 -2.15 -2.56 -0.16 -0.94 -3.6 -7.11
P/OCF Ratio -1.54 -0.82 -0.83 -2.19 -2.57 -0.16 -0.94 -3.61 -7.22
OCF/S Ratio n/a n/a n/a -19.61 n/a -11.69 n/a n/a n/a
Debt / Equity Ratio 1.14 0.52 0.62 0.53 0.18 0.37 0.21 -0.27 -0.21
Quick Ratio 5.34 5.76 6.27 6.97 13.68 6.50 10.48 0.37 1.26
Current Ratio 5.34 5.76 6.27 6.97 13.68 6.50 10.52 0.47 1.26
Asset Turnover n/a n/a n/a 0.02 n/a 0.10 n/a n/a n/a
Interest Coverage -18.61 -21.93 -23.37 -22.27 -24.08 -44.16 -17.38 -9.68 -31.41
Return on Equity (ROE) -1.98 -1.27 -1.38 -0.85 -0.44 -1.99 -0.58 0.41 0.39
Return on Assets (ROA) -0.69 -0.6 -0.76 -0.51 -0.35 -1.19 -0.42 -3.02 -1.39
Return on Capital (ROIC) -0.86 -0.66 -0.83 -0.54 -0.34 -1.5 -0.49 5.46 -5.23
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a 100.00% n/a 97.06% n/a n/a n/a
Net Profit Margin n/a n/a n/a -2.07K% n/a -1.23K% n/a n/a n/a
Pretax Profit Margin n/a n/a n/a -2.07K% n/a -1.23K% n/a n/a n/a
Operating Profit Margin n/a n/a n/a -2.00K% n/a -1.31K% n/a n/a n/a
FCF Margin n/a n/a n/a -2.01K% n/a -1.17K% n/a n/a n/a
EBITDA Margin n/a n/a n/a -1.94K% n/a -1.31K% n/a n/a n/a